Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06297343

Study of the Risk of Ischaemia Following the Creation of an Arteriovenous Fistula

The purpose of this study is to identify functional vascular changes and clinical factors correlated with the occurrence of short- or medium-term hand ischaemia after arteriovenous fistula creation.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Privé des Peupliers

Paris, 75013, France

Location status: Recruiting

About this study

This is a non-interventional, prospective, non-randomised, descriptive, single-centre study with no comparator.

The study population will be adult patients with chronic renal failure for whom an arteriovenous fistula has been planned.

Patients requiring the creation of an arteriovenous fistula by the surgeons at Hôpital Privé des Peupliers will be seen beforehand in the usual pre-operative consultation, during which the surgeon will explain the principle of the operation and the expected benefits/risks. On the day of surgery, patients will undergo the surgical procedure to create an arteriovenous fistula and will be discharged the same day. Patients will be reviewed during post-operative follow-up visits at 1, 6 and 12 months as in standard practice. All the data collected in the study were collected in routine medical practice.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years;
  • Stage 5 chronic kidney disease, on dialysis or not on dialysis;
  • Requiring the creation of an arteriovenous fistula;
  • Membership of a social insurance scheme;
  • Patient having been informed and having formulated his/her oral non-opposition to participate in the research.

Exclusion criteria

  • Contraindication to the proposed surgery ;
  • Reduced life expectancy in the opinion of the investigator;
  • Medical or biological conditions which, in the opinion of the investigator, could influence the interpretation of the results of the study or the safety of the patient;
  • Patient uncooperative with protocol requirements or unable to attend scheduled visits to the centre;
  • Other surgical or medical intervention planned during the study;
  • Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding;
  • Participating in another clinical trial, or in a period of exclusion from another clinical trial;
  • Patient under guardianship or deprived of liberty.

Treatment and study plan

Creation of an arteriovenous fistula

Procedure

Patients will undergo the surgical procedure to create an arteriovenous fistula and will be discharged the same day (outpatient care, or an overnight stay in hospital if they live a long way from the hospital, have multiple pathologies or are socially isolated). An arteriovenous fistula is created under local or general anaesthetic. On the day of the operation, the type of arteriovenous fistula created, the side of the arteriovenous fistula, the location of the arteriovenous fistula and the patency of the arteriovenous fistula will be collected.

Primary outcomes

  1. Occurrence of ischaemia of the hand

    Time frame: 12 months

    Number and proportion of patients with ischaemia (Yes = stages 1, 2 or 3/No = stage 0) according to the preoperative American Vascular Surgery ischaemia classification :

    0 - nothing

    • - cold hand
    • - pain on exercise and/or during dialysis
    • - permanent pain, wound (ulceration, necrosis, gangrene)

Study contacts

Contact information is provided by the study sponsor or research team.

Viviane DUEDAL, MD

CONTACT

[email protected]

6 70 80 18 98 ext. +33

Sponsors and collaborators

Lead sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche

Other

Collaborators

  • Euraxi Pharma

Registry information

Acronym: MODIFVASC

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Mar 7, 2024
Registry last updated
Nov 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.